Abstract:
Novel chip compositions comprise specifically defined carriers; benefit agent; and thickening agent (e.g., fumed silica). Use of chips comprising excess of these carriers over benefit agent and thickening agent has been found to allow significant deposition of benefit agent without compromising processing. In a second embodiment, the invention comprises bar compositions comprising mixtures of the chips of the invention and chips containing defined surfactant systems. A process for forming the chips of the invention and a method of enhancing deposition without compromising processing using the chips of the invention are also disclosed.
Abstract:
An implantable connector includes: first and second detachable mating parts configured to be implantable in living tissue, to terminate first and second segments of a cable, and have first and second interfacing surfaces, respectively; and a protection structure configured to protect against contaminant intrusion between the first and second interfacing surfaces. And a device for decoupling and re-coupling the detachable mating parts in an environmentally controllable volume is provided.
Abstract:
A personal care cleansing composition having enhanced perceptible skin benefits, for example, by selecting certain ratios of quaternary ammonium compounds and free fatty acids. Additionally, in accordance with various aspects of the present invention, the present inventors have discovered that the addition of talc in varying percentages increases qualities to the user such as freshness, smoothness, lather and creaminess. Additionally, aspects relating to fragrance retention, deposition and the amounts perceived are improved.
Abstract:
A prosthetic hearing device comprising a biocompatible housing having a surface that vibrates in response to sound waves traveling through tissue; and an interferometer mounted in the housing, the interferometer is constructed and arranged to generate a light beam that impinges on a reflective interior surface of the vibrating surface, and to receive light reflected from the reflective interior surface. The device detects ambient sound by impinging a light beam on a portion of the vibrating surface; receiving light reflected from the reflective portion; measuring the movement of the vibrating surface based on an interference pattern of the impinging and reflected light; and determining at least a frequency of the incident sound wave based on the interference pattern.
Abstract:
A method of imparting a rapid and a persistent antiviral activity against viral-mediated diseases is disclosed. The method includes applying an antimicrobial compositions containing (a) a disinfecting alcohol, (b) an organic acid, and (c) water, and having a pH of about 5 or less, to at least one of the nose, nasal passages, and surrounding facial areas of skin of an individual.
Abstract:
The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
Abstract:
A prosthetic hearing device comprising a biocompatible housing having a surface that vibrates in response to sound waves traveling through tissue; and an interferometer mounted in the housing, the interferometer is constructed and arranged to generate a light beam that impinges on a reflective interior surface of the vibrating surface, and to receive light reflected from the reflective interior surface. The device detects ambient sound by impinging a light beam on a portion of the vibrating surface; receiving light reflected from the reflective portion; measuring the movement of the vibrating surface based on an interference pattern of the impinging and reflected light; and determining at least a frequency of the incident sound wave based on the interference pattern.
Abstract:
Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides according to formulae (I) and (II) are disclosed where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
Abstract:
This invention provides SARM compounds and uses thereof in treating a variety of diseases or conditions in a subject, including, inter-alia, a muscle wasting disease and/or disorder or a bone-related disease and/or disorder.